Equity Method Investments (Details) In Millions, except Per Share data, unless otherwise specified	12 Months Ended					0 Months Ended	3 Months Ended				12 Months Ended								12 Months Ended					12 Months Ended				12 Months Ended				3 Months Ended	12 Months Ended
	Aug. 28, 2014 USD ($)	Aug. 29, 2013 USD ($)	Aug. 30, 2012 USD ($)	Aug. 29, 2013 Nanya [Member] Collaborative Arrangement Process Design and Process Development [Member] USD ($)	Aug. 30, 2012 Nanya [Member] Collaborative Arrangement Process Design and Process Development [Member] USD ($)	May 15, 2014 Inotera [Member] TWD	Aug. 28, 2014 Inotera [Member] USD ($)		Aug. 29, 2013 Inotera [Member] USD ($)		Aug. 28, 2014 Inotera [Member] USD ($)		Aug. 29, 2013 Inotera [Member] USD ($)		Dec. 31, 2012 Inotera [Member]	Aug. 30, 2012 Inotera [Member] USD ($)	Aug. 28, 2014 Inotera [Member] TWD	Aug. 29, 2013 Inotera [Member] TWD	Aug. 28, 2014 Inotera [Member] Inventories [Member] DRAM [Member] USD ($)	Aug. 29, 2013 Inotera [Member] Inventories [Member] DRAM [Member] USD ($)	Aug. 30, 2012 Inotera [Member] Inventories [Member] DRAM [Member] USD ($)	Aug. 28, 2014 Inotera [Member] Nanya [Member]	Aug. 28, 2014 Inotera [Member] Variable interest entity, not primary beneficiary [Member] USD ($)	Aug. 28, 2014 Tera Probe [Member] USD ($)	Aug. 29, 2013 Tera Probe [Member] USD ($)	Aug. 30, 2012 Tera Probe [Member] USD ($)	Aug. 28, 2014 Tera Probe [Member] JPY (¥)	Aug. 29, 2013 Tera Probe [Member] MMJ Acquisition [Member]	Aug. 28, 2014 Other [Member] USD ($)	Aug. 29, 2013 Other [Member] USD ($)	Aug. 30, 2012 Other [Member] USD ($)	Mar. 04, 2010 Other [Member] Transform [Member]	Aug. 30, 2012 Other [Member] Transform [Member] USD ($)	Aug. 28, 2014 Other [Member] Transform [Member] Origin Energy Limited [Member]
Schedule of Equity Method Investments [Line Items]
Investment Balance	$ 971	$ 396					$ 914	[1]	$ 344	[1]	$ 914	[1]	$ 344	[1]										$ 48	$ 40				$ 9	$ 12
Ownership Percentage (in hundredths)							33.00%	[1]	35.00%	[1]	33.00%	[1]	35.00%	[1]										40.00%	40.00%
Variable Interest Entity Entity Maximum Loss Exposure Amount From Investment Balance																							914
Equity in net income (loss) of equity method investees, net of tax	474	(83)	(294)								465		(79)			(189)								11	0	0			(2)	(4)	(105)
Equity Method Investment, Summarized Financial Information, Assets [Abstract]
Current assets	2,233	1,018
Noncurrent assets	2,502	2,634
Equity Method Investment, Summarized Financial Information, Liabilities [Abstract]
Current liabilities	1,417	1,912
Noncurrent liabilities	254	435
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract]
Net sales	3,382	1,788	1,798
Gross margin	1,576	1	(451)
Operating income (loss)	1,371	(203)	(751)
Net income (loss)	1,339	(188)	(793)
Equity [Abstract]
Payments to acquire equity method investments	0	0	187													170
Ownership percentage after stock transactions during period (in hundredths)																40.00%												40.00%				50.00%
Number of shares issued by Inotera						400							634
Stock price per share						31.50												9.47
Inotera ownership percentage before transaction						35.00%	35.00%		40.00%				40.00%
Ownership percentage in Inotera after its stock sale transaction						33.00%	33.00%		35.00%				35.00%
Gain from issuance of Inotera shares	93	48	0				93		48		93		48
Percentage interest held by a third party (in hundredths)																						33.00%												50.00%
Market value of equity interests							3,720				3,720													39
Equity Method Investment, Quoted Market Price Per Share																	51.90										¥ 1,087.00
Equity Method Investment, Difference Between Carrying Value and Quoted Market Value																								9
Amount in accumulated other comprehensive income (loss) for cumulative translation adjustments on its investment							44		44		44		44
Amortization of difference between cost and underlying equity in net assets																48
Percentage of Inotera's wafer production previously obligated to purchase (in hundredths)															50.00%
Purchases of DRAM products from Inotera																			2,680	1,260	646
Research and development	1,371	931	918	(19)	(138)
Difference between cost of Tera Probe investment and underlying equity																								26
Weighted-average period for remaining Inotera amortization (in years)																								6 years
Other than temporary impairment in Transform																																	69
Gain from disposition of interest in Aptina	$ 119	$ 0	$ 0

[1] (1) Entity is a variable interest entity.